4 shares to profit from a lower Australian dollar

Westfield Corp Ltd (ASX:WFD) and CSL Limited (ASX:CSL) are two attractive shares.

| More on:

The Fairfax press is reporting that Kerr Neilson the boss at Platinum Asset Management Limited (ASX: PTM) is predicting falls of up to 10% for the Australian dollar versus the US dollar in the next six to eight months ahead.

The prediction is largely based on the prospect of the US Fed starting an interest rate hiking cycle from December, while the local currency will come under more pressure due to tumbling commodity prices.

This makes sense and the stronger US dollar is a theme I have repeatedly suggested investors should look to leverage through 2015.

In my opinion a significant part (around three quarters) of ASX investors’ portfolios should have exposure to a stronger US dollar and overseas earnings. Especially so given the soft growth outlook for the Australian economy – generally share prices will not rise without growth!

Below are four stocks to consider for growth, overseas exposure, and a stronger US dollar.

ResMed Inc. (CHESS) (ASX: RMD) is a global healthcare business that issues chess depositary instruments on the ASX that represent a one tenth interest in the NYSE-listed scrip. The price of the local shares therefore is directly linked to the value of the US scrip. For example with ResMed’s US scrip currently selling for US$60 if the local dollar were to fall to US60 cents ResMed shares would be valued at $10 on an FX adjusted basis. It currently sells for $8.12.

Westfield Corp Ltd (ASX: WFD) Is the business that operates huge shopping centres in the US and Europe and offers investors both yield, defensive earnigns and strong exposure to the US dollar and economic growth. Dividends are paid in US dollars prior to being exchanged into Australian dollars and as the US rate cycle moves in the opposite direction to the Australian rate cycle I expect shares will be bid up in 2016. It currently sells for $9.64 and looks a buy.

CSL Limited (ASX: CSL) is the global healthcare giant that generates more than 40% of its revenues from North America, with virtually all the rest generated overseas. As a healthcare leader CSL enjoys powerful tailwinds with huge demand for its products that are used daily by hospitals the world over to provide treatment to patients that are often in emergency wards as trauma victims. This business looks a buy at $100.

Magellan Financial Group Ltd (ASX: MFG) is the international equities fund manager that invests a large portion of funds in US equities and prices its funds in US dollars. Revenues then benefit as the US dollar rises, while anyone positive on the outlook for the US economy in 2016 should also be attracted to the business as an excellent bet on US equity markets. At $26.80 the stock is slightly expensive, but I would not be surprised if it delivered a strong 2016.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

Motley Fool contributor Tom Richardson owns shares of Magellan Financial Group, ResMed Inc., and Westfield. You can find Tom on Twitter @tommyr345 Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing